Nancy E Avis1, Aimee Johnson2,3, Mollie Rose Canzona4, Beverly J Levine2. 1. Department of Social Sciences and Health Policy, Division of Public Health Sciences, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157-1063, USA. navis@wakehealth.edu. 2. Department of Social Sciences and Health Policy, Division of Public Health Sciences, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157-1063, USA. 3. Department of Health Sciences, James Madison University, 235 Martin Luther King Jr Way, Harrisburg, VA, 22807, USA. 4. Department of Communication, Wake Forest University, P.O. Box 7347, Winston-Salem, NC, 27109, USA.
Abstract
PURPOSE: This study aims (1) to estimate percentages of partnered women who are sexually active over the first 2 years post-breast cancer diagnosis; (2) to identify factors related to sexual inactivity; and (3) to evaluate separately, among both sexually active and inactive survivors, the relation between sexual problems and treatment-related variables, symptoms, and psychosocial factors. METHODS: Longitudinal observational study of breast cancer survivors recruited within 8 months of cancer diagnosis and followed for 18 months. The main outcome measures were (1) being sexually active/inactive in the past month and (2) sexual problems assessed with the four-item sexual problem domain of the Quality of Life in Adult Cancer Survivors (QLACS) scale. RESULTS: At baseline, 52.4% of women reported being sexually active in the past month. This percentage increased to 60.7% 18 months later. In multivariable repeated-measures analyses, age, past chemotherapy, depressive symptoms, and lower perceived attractiveness were related to inactivity. Sexually inactive women reported more problems on the QLACS than sexually active women. In stratified multivariable analyses, depressive symptoms were related to greater sexual problems for both sexually active and inactive women, as was vaginal dryness. Among the sexually active women, younger age at diagnosis, less illness intrusiveness, and lower perceived attractiveness were related to more problems. CONCLUSIONS: Research has shown that sexual functioning/sexual health are key aspects of quality of life for many cancer survivors, and are often not addressed by health care providers. Future studies should examine how such topics are handled by clinicians in their interactions with survivors.
PURPOSE: This study aims (1) to estimate percentages of partnered women who are sexually active over the first 2 years post-breast cancer diagnosis; (2) to identify factors related to sexual inactivity; and (3) to evaluate separately, among both sexually active and inactive survivors, the relation between sexual problems and treatment-related variables, symptoms, and psychosocial factors. METHODS: Longitudinal observational study of breast cancer survivors recruited within 8 months of cancer diagnosis and followed for 18 months. The main outcome measures were (1) being sexually active/inactive in the past month and (2) sexual problems assessed with the four-item sexual problem domain of the Quality of Life in Adult Cancer Survivors (QLACS) scale. RESULTS: At baseline, 52.4% of women reported being sexually active in the past month. This percentage increased to 60.7% 18 months later. In multivariable repeated-measures analyses, age, past chemotherapy, depressive symptoms, and lower perceived attractiveness were related to inactivity. Sexually inactive women reported more problems on the QLACS than sexually active women. In stratified multivariable analyses, depressive symptoms were related to greater sexual problems for both sexually active and inactive women, as was vaginal dryness. Among the sexually active women, younger age at diagnosis, less illness intrusiveness, and lower perceived attractiveness were related to more problems. CONCLUSIONS: Research has shown that sexual functioning/sexual health are key aspects of quality of life for many cancer survivors, and are often not addressed by health care providers. Future studies should examine how such topics are handled by clinicians in their interactions with survivors.
Entities:
Keywords:
Breast cancer; Cancer survivorship; Quality of life; Sexual problems
Authors: Pat Fobair; Susan L Stewart; Subo Chang; Carol D'Onofrio; Priscilla J Banks; Joan R Bloom Journal: Psychooncology Date: 2006-07 Impact factor: 3.894
Authors: Justine J Speer; Bruce Hillenberg; Dennis P Sugrue; Charla Blacker; Cynthia L Kresge; Veronica B Decker; Dana Zakalik; David A Decker Journal: Breast J Date: 2005 Nov-Dec Impact factor: 2.431
Authors: Vanessa M Barnabei; Barbara B Cochrane; Aaron K Aragaki; Ingrid Nygaard; R Stan Williams; Peter G McGovern; Ronald L Young; Ellen C Wells; Mary Jo O'Sullivan; Bertha Chen; Robert Schenken; Susan R Johnson Journal: Obstet Gynecol Date: 2005-05 Impact factor: 7.661
Authors: P Fobair; K O'Hanlan; C Koopman; C Classen; S Dimiceli; N Drooker; D Warner; H Davids; J Loulan; D Wallsten; D Goffinet; G Morrow; D Spiegel Journal: Psychooncology Date: 2001 Jan-Feb Impact factor: 3.894
Authors: Ilana B Addis; Stephen K Van Den Eeden; Christina L Wassel-Fyr; Eric Vittinghoff; Jeanette S Brown; David H Thom Journal: Obstet Gynecol Date: 2006-04 Impact factor: 7.661
Authors: Nancy E Avis; Beverly Levine; Michelle J Naughton; L Douglas Case; Elizabeth Naftalis; Kimberly J Van Zee Journal: Breast Cancer Res Treat Date: 2013-04-16 Impact factor: 4.872
Authors: Jennifer Barsky Reese; Kristen Sorice; Stephen J Lepore; Mary B Daly; James A Tulsky; Mary Catherine Beach Journal: Patient Educ Couns Date: 2018-10-04
Authors: Debra L Barton; Stephanie L Pugh; Patricia A Ganz; Steven C Plaxe; Bridget F Koontz; Jeanne Carter; Natalya Greyz-Yusupov; Seth J Page; Kendrith M Rowland; Ernie P Balcueva; Sobia Nabeel; Jack B Basil; Matthew L Hill; Carolyn Y Muller; Maria C Bell; Snehal Deshmukh; Lisa A Kachnic Journal: J Clin Oncol Date: 2021-12-09 Impact factor: 44.544
Authors: Neha Verma; Amanda L Blackford; Elissa Thorner; Jennifer Lehman; Claire Snyder; Vered Stearns; Karen Lisa Smith Journal: Breast Cancer Res Treat Date: 2022-10-05 Impact factor: 4.624
Authors: F M Nimbi; S Magno; L Agostini; A Di Micco; C Maggiore; B M De Cesaris; R Rossi; R Galizia; C Simonelli; R Tambelli Journal: Breast Cancer Date: 2022-01-06 Impact factor: 3.307
Authors: Hae Won Kim; Yeon Hee Kim; Saem Yi Kang; Eun Ju Lee; Jung Lim Lee; Youngji Kim Journal: Int J Environ Res Public Health Date: 2021-04-03 Impact factor: 3.390
Authors: Solveig K Smedsland; Kathrine F Vandraas; Synne K Bøhn; Alv A Dahl; Cecilie E Kiserud; Mette Brekke; Ragnhild S Falk; Kristin V Reinertsen Journal: Breast Cancer Res Treat Date: 2022-02-28 Impact factor: 4.872
Authors: Winnie Yeo; Elizabeth Pang; Giok S Liem; Joyce J S Suen; Rita Y W Ng; Christopher C H Yip; Leung Li; Claudia H W Yip; Frankie K F Mo Journal: Health Qual Life Outcomes Date: 2020-02-10 Impact factor: 3.186